NCT02118870View on ClinicalTrials.gov

Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent

PHASE4CompletedINTERVENTIONAL

Enrollment

1,500

Participants

Timeline

Start Date

June 10, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2018

Conditions

Acute Coronary Syndrome

Interventions

DRUG

Treatment 90 days DAPT

Short term DAPT arm: will continue DAPT with P2Y12 inhibitors and ASA up to 90 days, after which patients will continue.

DRUG

Treatment 360 days DAPT

Long term (360 days) DAPT arm: will continue DAPT with P2Y12 inhibitors and ASA up to 360 days, after which patients will continue on monotherapy with ASA only, unless contraindications for ASA emerge

All Listed Sponsors

lead

Diagram B.V.

OTHER

NCT02118870 - Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent | Biotech Hunter | Biotech Hunter